The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
Due to advancements in genetic engineering, small animal models are continuing to change in response to market needs. Model developers strive to better reflect the role of this important asset in both ...
Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...
Animal models are established, important tools for preclinical safety and efficacy testing. Companies are advancing more “humanized” models to better reflect human responses, while at the same time ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Scientists have developed a new method to simulate the complex movements of animals with exceptional accuracy. The research team set out to solve a long-standing challenge in biology -- how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results